<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04428177</url>
  </required_header>
  <id_info>
    <org_study_id>06/RVO-FNOs/2020</org_study_id>
    <nct_id>NCT04428177</nct_id>
  </id_info>
  <brief_title>Coronary Calcification Study - Intravascular Lithotripsy for Calcified Lesions</brief_title>
  <acronym>CCS</acronym>
  <official_title>Intravascular Lithotripsy in the Treatment of Calcified Coronary Lesions - Coronary Calcification Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective randomised study is to compare the safety and efficacy of novel
      intravascular lithotripsy (IVL) to the standard therapy of calcified coronary lesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will include a total of 40 patients with calcified coronary lesions who will be
      randomised 1:1 to the treatment with IVL (Shockwave; Shockwave Medical, Inc, Santa Clara,
      USA) or the standard therapy (non-compliat high-pressure or Scoreflex predilatation,
      rotational atherectomy, etc). Appropriate preparation of the lesions will be followed by DES
      implantation.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Minimal lumen diamether (MLD)</measure>
    <time_frame>1 year</time_frame>
    <description>minimal diamether of treated lesion measured by quantitative coronary angiography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Late luemn loss (LLL)</measure>
    <time_frame>1 year</time_frame>
    <description>difference between post-procedure MLD and 12-month MLD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Binary in-stent restenosis</measure>
    <time_frame>1 year</time_frame>
    <description>diamether stenosis ≥ 50% of reference vessel</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events (MACE)</measure>
    <time_frame>1 year</time_frame>
    <description>Cardiac death, myocardial infarction or tagret lesion revascularisation (TVR)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Angiographic success</measure>
    <time_frame>up to end of the procedure, an average of 2 hours</time_frame>
    <description>success in facilitating stent delivery with &lt;50% residual stenosis and without serious angiographic complications</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinical success</measure>
    <time_frame>up to discharge, an average of 3 days</time_frame>
    <description>angiographic success with no evidence of in-hospital MACE</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Coronary Artery Calcification</condition>
  <arm_group>
    <arm_group_label>Intrvascular Lithotripsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Calcified coronary lesions will be treated with intrvascular lithotripsy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard treatment of calcified coronary lesions: cutting, scoring or non-compliant balloon predilatation or rotational atherectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intravascular lithotripsy</intervention_name>
    <description>Intravascular lithotripsy uses sonic pressure waves to disrupt calcium with minimal impact to soft tissue of coronary vessel</description>
    <arm_group_label>Intrvascular Lithotripsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standart therapy</intervention_name>
    <description>conventional preparation of calcified lesion: non-compliant, cutting or scoring ballons predilatation or rotational atherectomy</description>
    <arm_group_label>Standard therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years

          -  Informed, written consent by the patient

          -  Ability to comply fully with the study protocol

          -  Negative pregnancy test (and effective contraception) in women with childbearing
             potential

        Angiographic inclusion criteria:

          -  Native coronary artery lesion with diameter stenosis ≥50% suitable for PCI

          -  Heavy calcification, defined as calcification within the lesion on both sides of the
             vessel assessed during angiography

          -  Reference vessel diameter (RVD) ≥2.5 mm with lesion length &lt;32 mm

          -  TIMI flow 3 of the target vessel at baseline

          -  No visible thrombus at target lesion site

        Exclusion Criteria:

          -  Cardiogenic shock or haemodynamic instability requiring mechanical circulatory support

          -  Active malignancy or other comorbidities with a life expectancy of 12 months

          -  Limited the possibility of control coronaro angiography (e.g., advanced renal failure)

          -  Known allergy to contrast agents (that cannot be adequately premedicated) or required
             concomitant dual antiplatelet therapy

          -  Current problems with substance abuse (e.g., alcohol or drugs)

          -  Subject is participating in another investigational drug or device clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Cardiovascular Diseases, University Hospital</name>
      <address>
        <city>Ostrava</city>
        <state>Česká Republika</state>
        <zip>70852</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 2, 2020</study_first_submitted>
  <study_first_submitted_qc>June 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2020</study_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary Artery Calcification</keyword>
  <keyword>Intravascular Lithotripsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcinosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

